DMC Biotechnologies has successfully demonstrated full commercial scale (85m3 fermentation at EW Biotech, Germany) for its first product, the amino acid L-alanine. The scale-up results identically tracked the performance at bench and pilot scales, further validating the predictability and scalability of DMC’s Dynamic Metabolic Control technology, inform the US company. Importantly, commercial performance metrics were demonstrated, meaning that no further strain improvements are required to achieve the target selling price.
Finnish company UPM takes the next transformative growth step and enters the biochemicals business by investing in a biorefinery at Leuna, Germany. The biorefinery will produce a range of 100% wood-based biochemicals which enable a switch from fossil raw materials to sustainable alternatives in various consumer-driven end-uses. The investment opens totally new markets for UPM with large growth potential for the future.
Global Bioenergies, the French biotech company that is developing a process to convert renewable resources into hydrocarbons through fermentation, announced yesterday that the construction of its demo plant, started mid-2015, is completed.
Global Bioenergies, French biotech compamy that is developing a process to convert renewable resources into hydrocarbons through fermentation, announces having obtained a 4.4 million euro loan from a consortium managed by BNP Paribas, Société Générale, CIC and Bpifrance to complete the financing of its demo plant in Germany. The loan, reimbursable over 5 years, is covered by guarantee funds of the Ile-de-France Region. The construction phase began yesterday and will last one year.
Europe’s first multi-purpose fermentation plant for the continuous production of bio-based chemicals has been recently inaugurated in Leuna, Saxony-Anhalt (Germany). Built at a cost of around 20 million euros, the facility will enable the German multinational conglomerate corporation ThyssenKrupp, one of the world’s largest steel producers (more than 43 billion euros in revenue), to further expand its research and development activities in the area of biochemicals based on renewable raw materials.